Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$2.58 -0.17 (-5.74%)
As of: Nov 10, 2026 · 11:40 AM EST

Galmed Pharmaceuticals (EOCN) Capital Leases (2019)

Updated

Galmed Pharmaceuticals (EOCN) recorded Capital Leases of $442,000 in Q2 2019.

Analysis

Galmed Pharmaceuticals (EOCN) Capital Leases (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Galmed Pharmaceuticals 1.40 Mn -43.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 442,000.00
API Access

Galmed Pharmaceuticals Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=EOCN&period=max&api_key=YOUR_API_KEY